The current valuation score of InMed Pharmaceuticals Inc is 9.24, ranking 45 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.70, which is -3099.52% below the recent high of 21.07 and -52.04% above the recent low of -1.07.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.